Jordan Nasri

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

18

H-Index

1

About

Dr. Jordan Nasri is a leading urologic oncologist and researcher whose work centers on improving prostate cancer staging through advanced imaging and predictive modeling. His primary research areas include microultrasound (MUS) technology, nomogram development for surgical planning, and the integration of imaging biomarkers into clinical decision-making. Dr. Nasri’s most notable contribution is the creation of a side-specific, microultrasound-based nomogram for predicting extracapsular extension (ECE) in prostate cancer—a critical factor in balancing oncologic resection with nerve-sparing surgery. This innovative tool, detailed in his 2022 highly cited paper (18 citations), offers a non-invasive alternative to multiparametric MRI, enabling more precise preoperative risk assessment. By leveraging MUS’s high-resolution imaging, his work directly addresses the clinical challenge of minimizing positive surgical margins while preserving patient quality of life. Dr. Nasri’s research has been recognized for its translational impact, bridging imaging technology and surgical outcomes. His nomogram is now being adopted in multiple centers, underscoring its value in personalized prostate cancer care. With a growing citation record and a focus on practical, patient-centered innovations, Dr. Nasri is shaping the future of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Side-specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate Cancer
18 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago